PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026
Key Highlights
- ➤PAVmed schedules third-quarter 2026 business update for November 13 at 8:30 AM ET
- ➤CEO Lishan Aklog will discuss operations and growth strategy
- ➤CFO Dennis McGrath will discuss third-quarter 2026 financial results
- ➤Lucid Diagnostics markets EsoGuard and EsoCheck for early esophageal precancer detection
- ➤Veris Health develops remote cancer monitoring and an implantable physiological monitor
Expert Statements
Lishan Aklog, M.D., Chairman and Chief Executive Officer of PAVmed
“will provide a business update and discuss the Companys operations and growth strategy”
Dennis McGrath, President and Chief Financial Officer of PAVmed
“will discuss the Companys third quarter 2026 financial results”
PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026 PR Newswire
NEW YORK, Oct. 30, 2026 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Friday, November 13, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D. , PAVmed's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath , PAVmed's President and Chief Financial Officer, will discuss the Company's third quarter 2026 financial results.
Get started
Create a free account to read the full story.